TY - JOUR
T1 - Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease
T2 - The multi-ethnic study of atherosclerosis
AU - Jensky, Nicole E.
AU - Allison, Matthew A.
AU - Loomba, Rohit
AU - Carnethon, Mercedes R.
AU - De Boer, Ian H.
AU - Budoff, Matthew J.
AU - Burke, Greg L.
AU - Criqui, Michael H.
AU - Ix, Joachim H.
N1 - Funding Information:
This study was supported by R21HL091217 (JHI) and associated ARRA supplement R21HL091217-01A2S1 (NJ and JHI), R01HL088451 (MAA), R01 HL071739 (MJB) and contracts N01-HC95159 through N01-HC-95165 and N01-HC-95169 all from the National Heart Lung and Blood Institute. The authors thank Ms. Clydene Nee for assistance with the manuscript, in addition to the other investigators and the staff of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org . This material is the result of work supported with resources of the VA San Diego Healthcare System.
PY - 2013/11
Y1 - 2013/11
N2 - Objective Lean muscle loss has been hypothesized to explain J-shaped relationships of body mass index (BMI) with cardiovascular disease (CVD), yet associations of muscle mass with CVD are largely unknown. We hypothesized that low abdominal lean muscle area would be associated with greater calcified atherosclerosis, independent of other CVD risk factors. Materials/Methods We investigated 1020 participants from the Multi-Ethnic Study of Atherosclerosis who were free of clinical CVD. Computed tomography (CT) scans at the 4th and 5th lumbar disk space were used to estimate abdominal lean muscle area. Chest and abdominal CT scans were used to assess coronary artery calcification(CAC), thoracic aortic calcification (TAC), and abdominal aortic calcification (AAC). Results The mean age was 64 ± 10 years, 48% were female, and mean BMI was 28 ± 5 kg/m2. In models adjusted for demographics, physical activity, caloric intake, and traditional CVD risk factors, there was no inverse association of abdominal muscle mass with CAC (prevalence ratio [PR] 1.02 [95% CI 0.95,1.10]), TAC (PR 1.13 [95%CI 0.92, 1.39]) or AAC (PR 0.99 [95%CI 0.94, 1.04]) prevalence. Similarly, there was no significant inverse relationship between abdominal lean muscle area and CAC, TAC, and AAC severity. Conclusion In community-living individuals without clinical CVD, greater abdominal lean muscle area is not associated with less calcified atherosclerosis.
AB - Objective Lean muscle loss has been hypothesized to explain J-shaped relationships of body mass index (BMI) with cardiovascular disease (CVD), yet associations of muscle mass with CVD are largely unknown. We hypothesized that low abdominal lean muscle area would be associated with greater calcified atherosclerosis, independent of other CVD risk factors. Materials/Methods We investigated 1020 participants from the Multi-Ethnic Study of Atherosclerosis who were free of clinical CVD. Computed tomography (CT) scans at the 4th and 5th lumbar disk space were used to estimate abdominal lean muscle area. Chest and abdominal CT scans were used to assess coronary artery calcification(CAC), thoracic aortic calcification (TAC), and abdominal aortic calcification (AAC). Results The mean age was 64 ± 10 years, 48% were female, and mean BMI was 28 ± 5 kg/m2. In models adjusted for demographics, physical activity, caloric intake, and traditional CVD risk factors, there was no inverse association of abdominal muscle mass with CAC (prevalence ratio [PR] 1.02 [95% CI 0.95,1.10]), TAC (PR 1.13 [95%CI 0.92, 1.39]) or AAC (PR 0.99 [95%CI 0.94, 1.04]) prevalence. Similarly, there was no significant inverse relationship between abdominal lean muscle area and CAC, TAC, and AAC severity. Conclusion In community-living individuals without clinical CVD, greater abdominal lean muscle area is not associated with less calcified atherosclerosis.
KW - Atherosclerosis
KW - Cardiovascular disease
KW - Lean muscle
UR - http://www.scopus.com/inward/record.url?scp=84886394228&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886394228&partnerID=8YFLogxK
U2 - 10.1016/j.metabol.2013.06.001
DO - 10.1016/j.metabol.2013.06.001
M3 - Article
C2 - 23916063
AN - SCOPUS:84886394228
SN - 0026-0495
VL - 62
SP - 1562
EP - 1569
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 11
ER -